Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Terminated 2Completed 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Pain 4Neoplasms 3Chronic Pain 1Cancer Pain 1Agnosia 1

Interventions

Radiotherapy 8Zoledronic Acid 7Fentanyl 7nabiximols 6Morphine 6Ibandronic Acid 6Ketamine 5Hydromorphone 5Analgesia 5Acetaminophen 5Tapentadol 4Oxycodone 4Acupuncture Therapy 4alvimopan 3Ropivacaine 3Prednisone 3Lidocaine 3cabozantinib 2Tetrodotoxin 2Mitoxantrone 2Gabapentin 2Duloxetine Hydrochloride 2Docetaxel 2Calcium 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2strontium chloride 1resiniferatoxin 1oxycodone-acetaminophen 1oxycodone naloxone combination 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Pain × Tapentadol × Clear all
NCT00472303 2019-11-04

A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine

Grünenthal GmbH

Phase 3 Completed
622 enrolled 31 charts

Cancer Pain, Neoplasms, Pain

NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated
31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

NCT00505414 2019-11-01

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

Grünenthal GmbH

Phase 3 Terminated
136 enrolled 9 charts

Neoplasms, Pain

NCT01165281 2017-07-21

A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain

Janssen Research & Development, LLC

Phase 3 Completed
343 enrolled 15 charts

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡